TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Chemoform Scandinavia AB
Closing information (x1000 NOK)
Closing information | 2023/10 | 2022/10 | 2021/10 |
Turnover |
73,816
|
98,348
|
113,028 |
Financial expenses |
4,584
|
620
|
723 |
Earnings before taxes |
-9,347
|
9,206
|
11,659 |
EBITDA |
-4,559
|
10,061
|
12,670 |
Total assets |
45,969
|
48,924
|
34,073 |
Current assets |
45,402
|
48,139
|
33,743 |
Current liabilities |
28,518
|
23,655
|
15,549 |
Equity capital |
17,451
|
24,019
|
17,429 |
- share capital |
1,003
|
945
|
981 |
Employees (average) |
17
|
14
![]() |
14 |
Financial ratios
Fiscal year | 2023/10 | 2022/10 | 2021/10 |
Solvency |
38.0%
|
49.1%
|
51.2% |
Turnover per employee |
4,342
|
7,025
|
8,073 |
Profit as a percentage of turnover |
-12.7%
|
9.4%
|
10.3% |
Return on assets (ROA) |
-10.4%
|
20.1%
|
36.3% |
Current ratio |
159.2%
|
203.5%
|
217.0% |
Return on equity (ROE) |
-53.6%
|
38.3%
|
66.9% |
Change turnover |
-30,479
|
-10,608
|
43,496 |
Change turnover % |
-29%
|
-10%
|
63% |
Chg. No. of employees |
3
|
0
|
4 |
Chg. No. of employees % |
21%
|
0%
|
40% |
Total value of public sale
Fiscal year | 2023/10 | 2022/10 | 2021/10 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.